Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.

@article{Berres2011SerumCC,
  title={Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.},
  author={M E Berres and Christian Trautwein and Maximilian Schmeding and Dennis Eurich and Frank Tacke and Marcus Bahra and Peter Neuhaus and Ulf Peter Neumann and Hermann Elard Wasmuth},
  journal={Hepatology},
  year={2011},
  volume={53 2},
  pages={596-603}
}
UNLABELLED The recurrence of liver fibrosis after liver transplantation (LT) for hepatitis C virus (HCV) infection is responsible for graft loss and patient mortality. Although the contribution of the immune system to fibrosis recurrence is anticipated, systematic studies evaluating immune parameters as predictive markers of allograft fibrosis are lacking. The infiltration of immune cells into the graft is governed by chemokines. Here we assessed the predictive value of serum levels of… CONTINUE READING